Wealth Enhancement Advisory Services’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$613K Buy
19,208
+1,249
+7% +$43.7K ﹤0.01% 2615
2026
Q2
$740K Buy
+17,959
New +$545K ﹤0.01% 2325

Other funds holding AGIO

Wealth Enhancement Advisory Services's AGIO Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its Agios Pharmaceuticals (AGIO) stake by 7% in Q3 2026, buying an estimated $43.7K and bringing the position to 19,208 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Wealth Enhancement Advisory Services first reported a position in AGIO in Q2 2026 and has held it in 2 quarters since. The position peaked at $740K in Q2 2026. 241 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Wealth Enhancement Advisory Services held 19,208 shares of Agios Pharmaceuticals worth $613K as of Q3 2026.
  • Wealth Enhancement Advisory Services bought 1,249 Agios Pharmaceuticals shares in Q3 2026, an estimated $43.7K.
  • Agios Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #2615 holding.
  • Wealth Enhancement Advisory Services first reported a position in Agios Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Wealth Enhancement Advisory Services's Agios Pharmaceuticals position peaked at $740K in Q2 2026.
  • 241 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.